257 related articles for article (PubMed ID: 1645591)
1. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
Thierry F; Howley PM
New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
[TBL] [Abstract][Full Text] [Related]
2. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
3. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
4. A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2.
Boeckle S; Pfister H; Steger G
Virology; 2002 Feb; 293(1):103-17. PubMed ID: 11853404
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome.
Kurg R; Uusen P; Võsa L; Ustav M
Virology; 2010 Dec; 408(2):159-66. PubMed ID: 20940072
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the separate regulation of the human papillomavirus type 11 E7 and E6 promoters by Viral cis sequences near the E6 promoter.
DiLorenzo TP; Chen D; Zhang P; Steinberg BM
Virology; 1998 Mar; 243(1):130-9. PubMed ID: 9527922
[TBL] [Abstract][Full Text] [Related]
7. The human papillomavirus type 18 (HPV18) replication protein E1 is a transcriptional activator when interacting with HPV18 E2.
Demeret C; Goyat S; Yaniv M; Thierry F
Virology; 1998 Mar; 242(2):378-86. PubMed ID: 9514974
[TBL] [Abstract][Full Text] [Related]
8. The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.
Stubenrauch F; Zobel T; Iftner T
J Virol; 2001 May; 75(9):4139-49. PubMed ID: 11287563
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.
Demeret C; Desaintes C; Yaniv M; Thierry F
J Virol; 1997 Dec; 71(12):9343-9. PubMed ID: 9371593
[TBL] [Abstract][Full Text] [Related]
10. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis.
Desaintes C; Demeret C; Goyat S; Yaniv M; Thierry F
EMBO J; 1997 Feb; 16(3):504-14. PubMed ID: 9034333
[TBL] [Abstract][Full Text] [Related]
11. Transcription-modulatory activity of full-length E6 and E6*I proteins of human papillomavirus type 16.
Shirasawa H; Jin MH; Shimizu K; Akutsu N; Shino Y; Simizu B
Virology; 1994 Aug; 203(1):36-42. PubMed ID: 8030282
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
Cripe TP; Alderborn A; Anderson RD; Parkkinen S; Bergman P; Haugen TH; Pettersson U; Turek LP
New Biol; 1990 May; 2(5):450-63. PubMed ID: 1963084
[TBL] [Abstract][Full Text] [Related]
13. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
Bernard BA; Bailly C; Lenoir MC; Darmon M; Thierry F; Yaniv M
J Virol; 1989 Oct; 63(10):4317-24. PubMed ID: 2476572
[TBL] [Abstract][Full Text] [Related]
14. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.
Dostatni N; Lambert PF; Sousa R; Ham J; Howley PM; Yaniv M
Genes Dev; 1991 Sep; 5(9):1657-71. PubMed ID: 1653173
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein.
Grm HS; Massimi P; Gammoh N; Banks L
Oncogene; 2005 Aug; 24(33):5149-64. PubMed ID: 15856010
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of a heterologous promoter by human cytomegalovirus immediate-early protein IE2.
Tsai HL; Kou GH; Tang FM; Wu CW; Lin YS
Virology; 1997 Nov; 238(2):372-9. PubMed ID: 9400610
[TBL] [Abstract][Full Text] [Related]
17. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.
Steger G; Corbach S
J Virol; 1997 Jan; 71(1):50-8. PubMed ID: 8985322
[TBL] [Abstract][Full Text] [Related]
19. The E2 trans-activating protein of bovine papillomavirus type 1 (BPV1) is serine-phosphorylated in vivo.
Meneguzzi G; Lathe R; Kieny MP; Vogt N
Oncogene; 1989 Nov; 4(11):1285-90. PubMed ID: 2554235
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
